HOXA9 regulates miR-155 in hematopoietic cells

Area of Science:

• Molecular Biology
• Hematopoiesis
• Gene Regulation

Background:

• Homeobox A9 (HOXA9) is a transcription factor involved in hematopoietic stem cell development.
• MicroRNAs (miRNAs) play critical roles in regulating gene expression during hematopoiesis.
• The precise regulatory relationship between HOXA9 and specific miRNAs in blood cell development is not fully understood.

Purpose of the Study:

• To investigate the role of HOXA9 in regulating microRNA expression in bone marrow (BM) cells.
• To determine if miR-155 is a downstream mediator of HOXA9 function in blood cell development.
• To identify potential targets of miR-155 in the context of HOXA9-mediated myelopoiesis.

Main Methods:

• Array-based microRNA expression profiling of HOXA9-deficient bone marrow cells.
• Confirmation of miR-155 expression using northern blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR).
• Infection of wild-type bone marrow cells with HOXA9-expressing lentivirus.
• Assessment of myeloid colony formation in miR-155-deficient versus wild-type bone marrow cells.
• Analysis of Pu.1 protein levels following miR-155 modulation.

Main Results:

• HOXA9 significantly up-regulates miR-155 expression in bone marrow cells.
• miR-155 expression levels correlate with HOXA9 mRNA levels in hematopoietic stem and progenitor cells.
• Deficiency in miR-155 blunts the capacity of HOXA9 to induce myeloid colony formation, establishing miR-155 as a downstream mediator.
• Pu.1 protein is identified as a direct target of miR-155, although HOXA9 does not modulate Pu.1 expression.

Conclusions:

• HOXA9 directly induces miR-155 expression in hematopoietic stem and progenitor cells.
• miR-155 is an essential downstream mediator of HOXA9's function in promoting myeloid differentiation.
• While miR-155 targets Pu.1, HOXA9's effect on myelopoiesis is mediated through miR-155 independently of Pu.1 modulation.